English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

FXYD1 negatively regulates Na+/K+-ATPase activity in lung alveolar epithelial cells

MPS-Authors
/persons/resource/persons224340

Wujak,  Lukasz A.
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224334

Seeger,  Werner
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224311

Morty,  Rory E.
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Wujak, L. A., Blume, A., Baloglu, E., Wygrecka, M., Wygowski, J., Herold, S., et al. (2016). FXYD1 negatively regulates Na+/K+-ATPase activity in lung alveolar epithelial cells. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 220, 54-61. doi:10.1016/j.resp.2015.09.008.


Cite as: http://hdl.handle.net/21.11116/0000-0001-BEF8-2
Abstract
Acute respiratory distress syndrome CARDS) is clinical syndrome characterized by decreased lung fluid reabsorption, causing alveolar edema. Defective alveolar ion transport undertaken in part by the Na+/K+-ATPase underlies this compromised fluid balance, although the molecular mechanisms at play are not understood. We describe here increased expression of FXYD1, FXYD3 and FXYD5, three regulatory subunits of the Na+/K+-ATPase, in the lungs of ARDS patients. Transforming growth factor (TGF)-beta, a pathogenic mediator of ARDS, drove increased FXYD1 expression in A549 human lung alveolar epithelial cells, suggesting that pathogenic TGF-beta signaling altered Na+/K+-ATPase activity in affected lungs. Lentivirus-mediated delivery of FXYD1 and FXYD3 allowed for overexpression of both regulatory subunits in polarized H441 cell monolayers on an air/liquid interface. FXYD1 but not FXYD3 overexpression inhibited amphotericin B-sensitive equivalent short-circuit current in Ussing chamber studies. Thus, we speculate that FXYD1 overexpression in ARDS patient lungs may limit Na+/K+-ATPase activity, and contribute to edema persistence. (C) 2015 Elsevier B.V. All rights reserved.